3,4-methylenedioxy-3',4',5'-trimethoxy chalcone
an anticancer prodrug designed to be activated into a potent tyrosine kinase inhibitor by the tumour selective enzyme activity of the cytochrome P450 enzyme CYP1B1; structure in first source
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Ankrett, Dyan N:
1 article
(01/2018)
|
2. | Arroo, Randolph R J:
1 article
(01/2018)
|
3. | Beresford, Kenneth J M:
1 article
(01/2018)
|
4. | Bhambra, Avninder S:
1 article
(01/2018)
|
5. | Butler, Paul C:
1 article
(01/2018)
|
6. | Ijaz, Taeeba:
1 article
(01/2018)
|
7. | Lodhi, Sabahat:
1 article
(01/2018)
|
8. | Potter, Gerard A:
1 article
(01/2018)
|
9. | Ruparelia, Ketan C:
1 article
(01/2018)
|
10. | Tan, Hoon L:
1 article
(01/2018)
|
Related Diseases
Related Drugs and Biologics